These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy? Dubaniewicz A; Zimmermann A; Dudziak M; Typiak M; Skotarczak M Expert Rev Clin Immunol; 2013 Apr; 9(4):349-60. PubMed ID: 23557270 [TBL] [Abstract][Full Text] [Related]
4. Sarcoidosis and tuberculosis: a connection to the human leukocyte antigen system. Dubaniewicz A; Zimmermann A; Smigielska M; Dubaniewicz-Wybieralska M; Moszkowska G; Wysocka J; Adamczyk-Bak K; Slominski JM; Deeg P Adv Exp Med Biol; 2013; 756():229-37. PubMed ID: 22836640 [TBL] [Abstract][Full Text] [Related]
5. Sarcoid arthritis: a review of clinical features, pathology and therapy. Torralba KD; Quismorio FP Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):95-103. PubMed ID: 12870718 [TBL] [Abstract][Full Text] [Related]
6. [Cutaneous manifestations of sarcoidosis]. Descamps V; Bouscarat F Ann Dermatol Venereol; 2016 Jan; 143(1):39-50. PubMed ID: 26804434 [TBL] [Abstract][Full Text] [Related]
12. Analysis of HLA antigens in Turkish sarcoidosis patients. Bilir M; Sipahi S; Yilmaz E; Midilli K; Yanardag H; Cagatay T; Demirci S; Karayel T; Erdogan E South Med J; 2007 Apr; 100(4):356-9. PubMed ID: 17458393 [TBL] [Abstract][Full Text] [Related]
13. Current therapy in sarcoidosis, the role of existing drugs and future medicine. Vorselaars AD; van Moorsel CH; Deneer VH; Grutters JC Inflamm Allergy Drug Targets; 2013 Dec; 12(6):369-77. PubMed ID: 24151828 [TBL] [Abstract][Full Text] [Related]